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International Society of Nephrology
Any elected member of a national society of nephrology
is eligible for membership in the International Society of
Nephrology, receipt of the Society's official journal,
Kidney International, and participation in the International
Congresses at a reduced registration fee. A subscription
to Kidney International is included in the annual dues of
US $ 33.00. Application forms for membership can be
obtained by writing to Dr. Herman Villarreal, Secretary
General of the International Society of Nephrology,
Departamento de Nefrologia, Instituto Nacional de Cardio-
logia, Avenida Cuauhtemoc 300, Mexico 7, D. F. Checks
for the first year's annual dues should be enclosed (payable
to the International Society of Nephrology).
Meetings
The next meeting of the American Society of Nephrology
will be held on November 19—20, 1973 at the Shoreham
Hotel, Washington, D.C.
The Council on the Kidney in Cardiovascular Disease of
the American Heart Association will hold its Fourth
Annual Postgraduate Seminar on March 12—13, 1973, on
the campus of the University of Pennsylvania, Philadelphia,
Pa. Program Director: Dr. Martin Goldberg. The program
will accent "Drugs, Hormones and the Kidney". Attend-
ance will be limited to 200 registrants. Registration forms
may be obtained from Dr. Alfred M. Bennett, Department
of Councils, American Heart Association, 44 F. 23rd
Street, New York, N.Y. 10010, U.S.A.
There will be a joint meeting of the Italian Society of
Nephrology and the French speaking societies (the French,
Belgian and Swiss Societies of Nephrology) in St. Vincent,
France, on May 26, 1973. The meeting will be devoted
primarily to new information derived from immuno-
fluorescent studies of kidney pathology and the utilization
of optimal methods of communication in nephrology.
Those members who wish to send proposals or suggestions
are invited to write to Prof. A. Vercellone, Ii Segretario,
Societa italiana di Nefrologia, Clinica Medica, Corso
Polonia 14, 10126 Torino.
Style Change for References in Kidney international
Authors should note that the present issue utilizes the
new style for References that was adopted recently by
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Kidney International, All future submissions should
conform to this style. Illustrative examples of the new
style are portrayed in the "Instructions for Authors".
Examinations of the American Board of Internal Medicine
It is planned that the next Subspecialty Areu Examina-
tion in Nephrology will be held October 15, 1974. Applica-
tions for admission should be requested on or about
January 1, 1974, and returned by March 15, 1974.
International Workshop on Risk/Benefit Assessment of
Cyclophosphamide in Renal Disease
An International Workshop was held in New York City
on June 11—13, 1972, to assess the therapeutic index ratio
of cyclophosphamide in patients with renal disease. The
Workshop was organized by the International Study of
Kidney Disease in Children and sponsored jointly by the
Kidney Foundation of New York and the National
Institute of Arthritis and Metabolic Diseases. Almost
forty participants attended. A transcript of the proceedings
is in preparation, but it seemed advisable that some of
the recommendations of the Workshop should be made
known to physicians who may be using cyclophosphamide
in the treatment of renal disease in view of its possible
gonadal toxicity in man.
Clinical data on the effectiveness of cyclophosphamide
in various renal diseases and its toxic effects in man and
experimental animals were reviewed. Committees were
formed to: 1) assess present knowledge of the drug and
make recommendations concerning its use in renal disease;
2) evaluate reports of general toxicity and make recom-
mendations concerning future studies on effectiveness
and toxicity; 3) evaluate present knowledge concerning
gonadal toxicity and make recommendations concerning
present and future evaluations of this problem.
The report of the Committee on General Toxicity will
appear in the full transcript; it will include suggestions
for proposed research needed for clinical appraisal.
The report of the Committee on Gonadal Toxicity in-
cluded information that administration of cyclophos-
phamide in prepubertal children may result in gonadal
damage manifested by sterility as young adults. The
Committee advised an immediate gathering of observations
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